Abridge Inc
PrivateLast Round
Series E
Jun 24, 2025
Est. Valuation
$5.3B
Total Funding Raised
$747.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Abridge Inc is a healthcare technology company that provides an AI-powered platform for clinical documentation by transcribing and summarizing patient-clinician conversations.
Sector
Healthcare & Life Sciences
Verticals
NLP & Conversational AI, EHR & EMR, Medical AI, Clinical Trials, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Price History
Caplight MarketPrice™ estimate for Abridge Inc, published with a 90-day delay.
Caplight MarketPrice™
$180.87
per share, as of June 2026
-23.9%
8-month change
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Abridge Inc Comparables
Compare Abridge Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Commure | 90% | |
| Suki | 88% | |
| Ambience Healthcare | 88% |
Abridge Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 24, 2025 | ||||
| Series D | Feb 17, 2025 | ||||
| Series C | Feb 23, 2024 | ||||
| Series B | Oct 26, 2023 | ||||
| Series A Extension | Aug 11, 2022 | ||||
Seed | Oct 6, 2020 |
Key People
Founding team and executive leadership
Abridge Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series E |
| SV Angel | Series D |
| California Health Care Foundation | Series D |
| Aetna Ventures | Series B |
| Union Square Ventures | Series C, Series A Extension, Series B, Seed |
| Kaiser Permanente Ventures | Series B, Series C |
| Khosla Ventures | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Grew 20% QoQ, from 532 to 637 employees.
- Jun 21, 2026
Added Inova Health System as a customer.
Recent news
Latest coverage and updates
- invests_intoSep 22, 2026
Pillar invested into Amplifyer Bio, Inc. $7M in Seed on Sep 22nd '26.
- invests_intoSep 16, 2026
Pillar invested into g5labs $14M in Seed on Sep 16th '26.
Abridge Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abridge Inc's valuation, stock price, and market status.
Is Abridge Inc a public or private company?
Abridge Inc is a private company.
What is the current stock price of Abridge Inc?
Abridge Inc is a private company, so its shares have no public market price. Caplight tracks Abridge Inc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abridge Inc worth (valuation)?
Abridge Inc's valuation is estimated at $5.3B based on funding round data.
Can I buy Abridge Inc stock?
Abridge Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abridge Inc's last funding round?
Abridge Inc's most recent funding round was Series E on June 24, 2025.
Who are the main investors in Abridge Inc?
Key investors in Abridge Inc include Andreessen Horowitz, Union Square Ventures, UPMC, Spark Capital, Institutional Venture Partners (IVP).
Will Abridge Inc IPO soon?
No public IPO plans have been announced for Abridge Inc.
How can I track Abridge Inc secondary market activity?
Caplight tracks bids, offers, and trades in Abridge Inc's shares on secondary markets.